UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity

Nature communications, 2020-03, Vol.11 (1), p.1508-12, Article 1508

2020

Volltextzugriff (PDF)

Breaking Down the Barriers to Precision Cancer Nanomedicine

Trends in biotechnology (Regular ed.), 2017-02, Vol.35 (2), p.159-171

2017

Volltextzugriff (PDF)

Pathway signature and cellular differentiation in clear cell renal cell carcinoma

PloS one, 2010-05, Vol.5 (5), p.e10696-e10696

2010

Volltextzugriff (PDF)

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy

Nature nanotechnology, 2017-08, Vol.12 (8), p.763-769

2017

Volltextzugriff (PDF)

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

Scientific reports, 2016-05, Vol.6 (1), p.26269, Article 26269

2016

Volltextzugriff (PDF)

Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target

The journal of clinical endocrinology and metabolism, 2015-05, Vol.100 (5), p.E697-E709

2015

Volltextzugriff (PDF)

Neuronal Pentraxin 2 Supports Clear Cell Renal Cell Carcinoma by Activating the AMPA-Selective Glutamate Receptor-4

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (17), p.4796-4810

2014

Volltextzugriff (PDF)

Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma

Clinical cancer research, 2013-05, Vol.19 (9), p.2368-2380

2013

Volltextzugriff (PDF)

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

Nature communications, 2024-07, Vol.15 (1), p.5871-20, Article 5871

2024

Volltextzugriff (PDF)

Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers

Molecular cancer therapeutics, 2012-10, Vol.11 (10), p.2105-2115

2012

Volltextzugriff (PDF)

IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies

Frontiers in immunology, 2023-10, Vol.14, p.1239082-1239082

2023

Volltextzugriff (PDF)

Designing nanomedicine for immuno-oncology

Nature biomedical engineering, 2017-02, Vol.1 (2), Article 0029

2017

Volltextzugriff (PDF)

Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery

Advanced science, 2019-03, Vol.6 (5), p.1802070-n/a

2019

Volltextzugriff (PDF)

Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases

Clinical cancer research, 2023-05, Vol.29 (9), p.1751-1762

2023

Volltextzugriff (PDF)

Lessons from immuno-oncology: a new era for cancer nanomedicine?

Nature reviews. Drug discovery, 2017-06, Vol.16 (6), p.369-370

2017

Volltextzugriff (PDF)

Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration

Oncotarget, 2014-07, Vol.5 (14), p.5320-5334

2014

Volltextzugriff (PDF)

Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions

Cancer research (Chicago, Ill.), 2019-04, Vol.79 (7), p.1535-1548

2019

Volltextzugriff (PDF)

Investigation and modulation of interleukin-6 following subarachnoid hemorrhage: targeting inflammatory activation for cerebral vasospasm

Journal of neuroinflammation, 2022-09, Vol.19 (1), p.1-228, Article 228

2022

Volltextzugriff (PDF)

Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma

Expert opinion on therapeutic targets, 2016-02, Vol.20 (2), p.159-166

2016

Volltextzugriff (PDF)

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors

Genome medicine, 2024-01, Vol.16 (1), p.17-19, Article 17

2024

Volltextzugriff (PDF)

Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy

Oncotarget, 2018-01, Vol.9 (1), p.3-20

2018

Volltextzugriff (PDF)

An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development

Journal of Cancer, 2011-01, Vol.2 (1), p.142-152

2011

Volltextzugriff (PDF)

875 CA-4948 alters tumor associated macrophage activity in the tumor microenvironment of murine models of melanoma metastases

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A975-A975

2023

Volltextzugriff (PDF)

772 Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A867-A869

2023

Volltextzugriff (PDF)

362 Priming of the Brain Tumor Microenvironment Enables Improved Nanomedicine Delivery

Neurosurgery, 2016-08, Vol.63 (CN_suppl_1), p.207-207

2016

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(83)
Dissertationen
(1)

Sprache

Englisch
(84)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(23)
Humans
(22)
Oncology
(14)
Tumors
(14)
Cell Line, Tumor
(12)
Animals
(11)
Immunotherapy
(8)
Cancer
(7)
Cell Biology
(7)
Nanoparticles
(7)
Tumor Microenvironment
(7)
Brain Cancer
(6)
Female
(6)
Kidney Neoplasms - Pathology
(6)
Mice
(6)
Science & Technology - Other Topics
(6)
Carcinoma, Renal Cell - Genetics
(5)
Carcinoma, Renal Cell - Pathology
(5)
Gene Expression Regulation, Neoplastic
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity

Breaking Down the Barriers to Precision Cancer Nanomedicine

Pathway signature and cellular differentiation in clear cell renal cell carcinoma

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target

Neuronal Pentraxin 2 Supports Clear Cell Renal Cell Carcinoma by Activating the AMPA-Selective Glutamate Receptor-4

Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers

IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies

Designing nanomedicine for immuno-oncology

Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery

Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases

Lessons from immuno-oncology: a new era for cancer nanomedicine?

Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration

Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions

Investigation and modulation of interleukin-6 following subarachnoid hemorrhage: targeting inflammatory activation for cerebral vasospasm

Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors

Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy

An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development

875 CA-4948 alters tumor associated macrophage activity in the tumor microenvironment of murine models of melanoma metastases

772 Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy

362 Priming of the Brain Tumor Microenvironment Enables Improved Nanomedicine Delivery

Suchergebnisse filtern